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Background: The last decade has seen a proliferation in the number and diversity 
of anticoagulant and antiplatelet agents used in clinical medicine. In addition their 
clinical indications have expanded. This has served to increase the longevity and 
reduce the morbidity of patients with vascular disease including a significant number 
of patients who present with fragility fractures of the femoral neck. Antiplatelet 
agents and anticoagulants increase the risk attendant to both surgical and 
anaesthetic intervention. There is wide variation in clinical practice with regard to 
the peri-operative use of a number of anticoagulant and anti-platelet drugs, but 
recently multiple professional bodies have released guidelines on the management 
of patients requiring urgent surgery with these agents.  
 
Objective: The objective of this study was to synthesise the published guidelines for 
the management of different antiplatelet and anticoagulant agents during the peri-
operative period for patients undergoing urgent surgery into a single source for easy 
reference.  
 
Methods: A search of Pubmed and websites of anaesthetic, medical, haematological 
and surgical professional societies was performed for English language guidelines for 
peri-operative management of patients on anticoagulant or antiplatelet agents 
undergoing surgery for fracture neck of femur or urgent surgery in general. 
Guidelines for individual agents were compiled into a single table for reference. 
 
Results: Relevant guidelines were identified from the Scottish Intercollegiate 
Guidelines Network, Association of Anaesthetists of Great Britain and Ireland, 
American College of Chest Physicians, British Society of Haematologists and the 
American Society of Regional Anaesthesia and Pain Medicine. With the exception of 
the Scottish Intercollegiate Guidelines Network, guidelines related to emergency 
surgery rather than hip fragility fractures. A synthesis of the guidelines suggests that 
aspirin monotherapy should not delay surgery nor prevent neuraxial anaesthesia. 
clopidogrel and other P2Y12 receptor inhibitors should not delay surgery and general 
anaesthesia is preferable to neuraxial anaesthesia. Warfarin should be reversed 
partially or completely with intravenous phytomenadione. Surgery should be 
delayed for at least 24-48 hours after the last dose of factor Xa and thrombin 
inhibitors. 
 
Conclusions: The guidelines of professional bodies suggest that antiplatelet 
monotherapy should not delay surgery for fractured neck of femur and the ready 
reversibility of warfarin should also not delay operation. The situation regarding 
direct oral anticoagulants is more complicated, but antidotes to some of these 
medications are becoming available and may reduce the time delay required before 
operation for neck of femur fracture. 
